The report provides a detailed analysis essential for establishing a colchicide production plant. It encompasses all critical aspects necessary for colchicide production, including the cost of colchicide production, colchicide plant cost, colchicide production costs, and the overall colchicide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a colchicide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Colchicide, alternatively known as demethoxycolchicine, is a close structural analogue of colchicine with the C-10 methoxy group replaced by hydrogen. It is used by researchers to probe colchicine-tubulin interactions, as its simplified binding kinetics help dissect the two-step mechanism of colchicine recognition. It functions as a tool for studying microtubule dynamics, cell cycle arrest at G2/M, and potential antimitotic therapies without the full metabolic liabilities of colchicine.
The market growth for colchicide is driven by the rising prevalence of gout, autoinflammatory disorders (e.g., familial Mediterranean fever), and cardiovascular applications amid ageing populations and urbanisation in Asia-Pacific regions like India and China. The growing research into tubulin inhibitors for antimitotic therapies and cancer studies, where colchicide's simplified binding kinetics offer advantages over colchicine boosts the market growth. Additionally, supply chain needs for analogues in drug discovery pipelines fuel the market expansion. Generic competition, formulation innovations (e.g., tablets, injectables), and digital health integration further propel related procurement. However, supply chain vulnerabilities, including limited global producers and reliance on specialised extraction or synthesis, impact industrial colchicide procurement, prompting strategies like multi-supplier diversification, direct sourcing from manufacturers, and volume commitments to mitigate shortages.
Raw Material for Colchicide Production
According to the colchicide production plant project report, the various raw materials for colchicide production include Colchicum autumnale corms.
Production Process of Colchicide
The extensive colchicide production cost report consists of the following major industrial production process:
- Production via selective O-demethylation: The production process of colchicide starts with colchicine extraction from Colchicum autumnale corms via grinding, ultrasonic-assisted aqueous two-phase extraction (ethanol-water-salt at 40-70 degree Celsius). The extraction is followed by filtration, chloroform partitioning, macroporous resin purification (D3520 with dilute sulfuric acid), and recrystallisation from ethyl acetate at 0-10 degree Celsius for >95% purity. The conversion to colchicide proceeds through selective O-demethylation at C-10, preferably via microbial biotransformation using Pseudomonas or Streptomyces enzymes on biorhizomes for high specificity and low waste, or chemically with BBr3/HBr (40-50% yield). The final purification involves chromatography, crystallisation, vacuum drying at 50-60 degree Celsius, and HPLC verification (>98% purity) under GMP to preserve tubulin-binding activity.
Colchicide, or demethoxycolchicine (C21H23NO5), is a structural analogue of colchicine (C22H25NO6) lacking the C-10 methoxy group, resulting in a slightly lower molecular weight of 369.4 g/mol and altered lipophilicity that enhances its tubulin binding kinetics. It retains the core trimethoxybenzoyl tropolone structure with a seven-membered acetamido-substituted ring B, a stereocentre at C-7 (S configuration), and a chiral axis between rings A and C. It is sparingly soluble in water but soluble in organic solvents like DMSO and ethanol, with a melting point near colchicine's 142–150 degree Celsius range due to similar crystallinity.